About
Small Molecule Discovery
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (7)
Dr. Josep Prous Jr.
Co-Founder, CSO and Board Member
Connecta Therapeutics
executivefounder
Dr. Mara Dierssen
Research Advisor / Group Leader at the Center for Genomic Regulation, Barcelona
Connecta Therapeutics
advisor
Dr. Marta Pascual
Director of Research & Development
Connecta Therapeutics
team_member
Dr. Randi Hagerman
Clinical Advisor / Medical Director, UC Davis MIND Institute, San Francisco (US). Distinguished Professor, Endowed Chair in Fragile X Research.
Connecta Therapeutics
board_chairadvisor
Irene Domingo
Project Manager
Connecta Therapeutics
team_member
Jordi Fàbrega
Co-Founder, CEO and Board Member
Connecta Therapeutics
executivefounder
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
96
By Phase
PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06957054Lead Sponsor
Neural Biomarkers in Fragile X Syndrome
N/ACompleted
20 participants
Started: Dec 16, 2024 · Completed: Mar 20, 2025
NCT06480968Lead Sponsor
CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction
PHASE1Completed
76 participants
Started: Jun 23, 2023 · Completed: Nov 11, 2024
Locations (1)
Headquarters
Barcelona, Spain
Map
Loading map...